iKang Healthcare Group, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2018 12 months to Mar 31, 2018	FY2017 12 months to Mar 31, 2017	FY2016 12 months to Mar 31, 2016	FY2015 12 months to Mar 31, 2015	FY2014 12 months to Mar 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization
Share-based compensation expenses
Impairment of property and equipment
Loss on liquidation of a subsidiary
Gain from disposal of cost method investment
Allowance for doubtful accounts
Inventory written-down
Amortization of discount on payable purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd
iKang Shanghai Xikang Road
Total amortization of discount on payable purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd
Loss from equity method investment
Loss from equity method investments
Fair value change of previously held 33% equity interest of Shanghai Huajian Health Examination Management Co., Ltd

Changes in assets and liabilities
Accounts receivable
Inventories
Prepaid expenses and other current assets
Deferred tax assets
Rental deposit and other long-term assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenues
Income tax payable
Deferred government subsidy
Deferred tax liabilities
Net cash provided by generated from operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Restricted cash
Purchase of non-controlling interest
Term deposits
Purchase of property and equipment
Proceeds from disposal of property and equipment
Purchase of assets
Purchase of intangible assets
Purchase of non-controlling interest
iKang Shanghai Lujiazui
Shenzhen Hospital Management
iKang Shanghai Gubei
Fujian iKang
Beijing Tianzhikangjian

Payments for business acquisitions (net of cash acquired of $10,165 and $6 and $516 for years ended March 31, 2016, 2017 and 2018, respectively)
Prepayment for business acquisitions
Payment for long-term investments
Return of prepayment for long-term investments
Proceeds from sale of cost method investment
Loan provided to related parties
Repayment of loan by related parties
Proceeds from disposal of the subsidiaries
Payment of loan receivables
Proceeds from issuance of convertible redeemable preferred shares
Proceeds from redesignation of convertible redeemable preferred shares
Proceeds from redesignation of Class A common shares
Payments for professional fees in connection of issuance of series F convertible preferred shares
Net cash used in investing activities

CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from issuance of common shares upon initial public offering
Proceeds from issuance of common shares upon Green Shoe
Payments of initial public offering cost
Proceeds from exercise of share options
Capital contribution from non-controlling interest shareholders
iKang Changzhou
Beijing Jiandatong
Total capital contribution from non-controlling interest shareholders

Purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd.
Return of capital to non-controlling interest shareholders
Dividend distribution to non-controlling interest shareholders
iKang Shanghai Xikang Road
iKang Shanghai Gubei
MediFast
Total dividend distribution to non-controlling interest shareholders

Dividend distribution to non-controlling interest shareholder of Shanghai Guobin Medical Center Co., Ltd
Payments for assets acquisition
Proceeds from long-term loans
Payments for business acquisitions
Proceeds from financing agreement in relation with New China Life Insurance Health Investment Management Co., Ltd
Proceeds from long-term borrowings
Repayment of convertible loan
Effect of exchange rate on cash and cash equivalent
Proceeds from short-term borrowings
Repayments of short-term borrowings
Repayments of long-term borrowings
Net cash provided by (used in) financing activities

Effect of exchange rate on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR
CASH AND CASH EQUIVALENTS AT END OF THE YEAR
Supplemental cash flow information
Income tax paid
Interest paid
Supplemental non-cash financing and investing activities
Payable for purchase of non-controlling interest of Shanghai Guobin Medical Center Co., Ltd.
Payable for business acquisitions
Payable for assets acquisitions
Payable for purchase of long term investments
Payable for purchase of property and equipment
Prepayment for business acquisitions
Prepayment for long term investments
Prepayment for purchase of property and equipment
Capital contribution, through other assets, relating to non-controlling interest

Comments